From Minimal Residual Disease To Maintenance Therapy: Optimizing Tools For Treatment Of Mantle Cell Lymphoma
ONCOLOGY-NEW YORK(2016)
摘要
Overall, the future of patients with MCL is promising, since therapeutic options have widened. The implementation of universal aggressive treatment is challenged by novel regimens, targeted agents, the use of MRD to guide treatment decisions, and new trials that will directly compare transplant vs non-transplant approaches.
更多查看译文
关键词
mantle cell lymphoma,cell lymphoma,minimal residual disease,maintenance therapy
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要